Literature DB >> 21438672

Comparative use of biomedicine and Chinese medicine in Taiwan: using the NHI Research Database.

Chu-Chin Tu1, Chu-Shiu Li, Chin-Ming Liu, Chwen-Chi Liu.   

Abstract

OBJECTIVES: Users of Traditional Chinese Medicine (CM) and biomedicine (BM) are commonly assumed to belong to two different groups in most of the related literature. The purpose of this article is to compare the characteristics of those who use both CM and BM for the same illness (CBMS) with those who solely use BM (BMS).
METHODS: Starting with a systematic sampling of 200,000 patients from a database of the Taiwan National Health Insurance program for the year 1999, the data were organized so that those who visited hospitals and clinics more than twice for the same illness were selected. In total, there were 96,872 (60%) BM users and 30,099 (19%) CBM users. The χ(2) test and mean test were applied to compare the differences in use between the above two subgroups. Logistic regression was used to calculate odds ratios of demographic variables and disease types.
RESULTS: Compared to the group using BM for the same illness (BMS), there were more females in the group using both CM and BM for the same illness (CBMS) (p < 0.0001). Most of the subjects in the CBMS group were aged 25-49 years (p < 0.0001). The mean number of total visits was higher for CBMS (16.33) than for BMS (13.71) (p < 0.0001). For both groups, the mean number of visits for females was higher than for males (p < 0.0001). Furthermore, the mean cost per visit was significantly lower for CBMS (519.58 New Taiwan Dollar [NTD]) than for BMS (582.37 NTD). Among the top eight major disease categories of patients in the two subgroups, disease of the respiratory system was the most common primary indication in both CBMS and BMS. However, diseases of the musculoskeletal system and injury showed the highest incidences in CBMS when compared with BMS.
CONCLUSIONS: Alternative medicinal treatment has become increasingly popular in recent years. Providing integrated CM and BM service in one medical facility might greatly benefit patients.

Entities:  

Mesh:

Year:  2011        PMID: 21438672     DOI: 10.1089/acm.2010.0200

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  4 in total

1.  Use of Chinese medicine correlates negatively with the consumption of conventional medicine and medical cost in patients with uterine fibroids: a population-based retrospective cohort study in Taiwan.

Authors:  Shan-Yu Su; Chih-Hsin Muo; Donald E Morisky
Journal:  BMC Complement Altern Med       Date:  2015-04-23       Impact factor: 3.659

2.  Improved medical expenditure and survival with integration of traditional Chinese medicine treatment in patients with heart failure: A nationwide population-based cohort study.

Authors:  Ming-Yen Tsai; Wen-Long Hu; Jen-Huai Chiang; Yu-Chuen Huang; Shih-Yu Chen; Yu-Chiang Hung; Yung-Hsiang Chen
Journal:  Oncotarget       Date:  2017-08-08

3.  Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study.

Authors:  Zhengwei Huang; Xuefeng Shi; Stephen Nicholas; Elizabeth Maitland; Yong Yang; Weihan Zhao; Yong Ma; Yan Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-29       Impact factor: 2.629

4.  Use of chinese medicine and subsequent surgery in women with uterine fibroid: a retrospective cohort study.

Authors:  Shan-Yu Su; Chih-Hsin Muo; Donald E Morisky
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-16       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.